Subscribe Here!

Enabling Bioprocessing 4.0 with Culture Biosciences and 908 Devices

Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...

Culture Solutions: Systematic & Automated Analysis for Cell Line Screening

Cell line screening and development plays a fundamental role in the biopharmaceutical industry,...

The Mysterious Case of the Missing Glucose

Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...

Introducing a New Cell Line Screening Paradigm

revised December 15, 2022

How empowering cell line engineering groups with Culture's cloud...

How Culture Biosciences is Scaling Up: An Interview with Our First Employee

Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...

The Global Biomanufacturing Capacity Problem

While you may be aware that synthetic biology is on the rise, you may not know that there’s a major...

When should I start using bioreactors?

Many of Culture’s clients have questions pertaining to the right time to transition to bioreactors...

How to De-Risk Bioprocess Scale-Up

Scaling up a bioprocess can be challenging, but thorough preparation for scale-up early in the...

3 Alternative Feeding Strategies to Improve Cell Line Performance

revised December 16, 2022

In addition to the multitude of different biological pathways and ...

Leveraging Dynamic Feed Strategies to Accelerate Bioprocess Timelines

revised December 16, 2022

Using dynamic feeds to facilitate successful bioprocess development and...

1 2 3